BIRC5 and acute lymphoblastic leukemia: Mechanistically, we show this prosurvival phenotype is driven by enhanced JAK/STAT and identify BIRC5 as a specific genetic dependency and therapeutic vulnerability of DNMT3A-mutant T-ALL cells.